Anchor Capital Advisors buys $29,897,565 stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Anchor Capital Advisors scooped up 128,335 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 306,862 shares of CVS Health Corp which is valued at $29,897,565.CVS Health Corp makes up approximately 0.77% of Anchor Capital Advisors’s portfolio.

Other Hedge Funds, Including , Veritas Asset Management Llp boosted its stake in CVS in the latest quarter, The investment management firm added 439,848 additional shares and now holds a total of 4,808,477 shares of CVS Health Corp which is valued at $468,489,914. CVS Health Corp makes up approx 4.88% of Veritas Asset Management Llp’s portfolio.Focused Investors reduced its stake in CVS by selling 27,400 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 1,608,100 shares of CVS which is valued at $155,262,055. CVS Health Corp makes up approx 5.85% of Focused Investors’s portfolio. Tnb Financial sold out all of its stake in CVS during the most recent quarter. The investment firm sold 2,080 shares of CVS which is valued $201,760.Hills Bank Trust Co boosted its stake in CVS in the latest quarter, The investment management firm added 1,910 additional shares and now holds a total of 30,015 shares of CVS Health Corp which is valued at $2,911,455. CVS Health Corp makes up approx 1.04% of Hills Bank Trust Co’s portfolio.

CVS Health Corp closed down -0.46 points or -0.47% at $96.97 with 41,25,962 shares getting traded on Thursday. Post opening the session at $97.26, the shares hit an intraday low of $96.27 and an intraday high of $97.93 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *